Single and dual agonists The fundamental difference between these two molecules is that semaglutide is a GLP-1 agonist, i.e., it has a strong structural similarity (95%) with this hormone and specifically activates its receptor, while tirzepatide is a dual agonist, i.e., it has a hybrid structure that allows it to activate both GLP-1 and GIP receptors (Figure 2)
Semaglutide works by mimicking a hormone called GLP-1 (glucagon-like peptide-1), which regulates appetite and food intake
This website will not assume any legal responsibility for the patients medical condition.
When starting GLP-1 medications, many people want to know how long the drug stays in the body
"Make your skin lighter, smoother and younger!" pm lang
A total of 35 biological replicates were analyzed per tissue per acyl substrate